Mayo Clinic | Strategic Alliance Partners

Latest from Mayo Clinic


Dr. Mesa on NCCN Guidelines for MPNs

October 26, 2016

Ruben A. Mesa, MD, chair, Division of Hematology and Medical Oncology, deputy director, professor of Medicine, Mayo Clinic, discusses the NCCN guidelines for treatment of patients with myeloproliferative neoplasms (MPNs).

Dr. Fonseca on Pivotal Trials in Multiple Myeloma

October 20, 2016

Rafael Fonseca, MD, professor of Medicine, Mayo Clinic, discusses some of the ongoing clinical trials that could be potentially practice changing for the treatment of patients with multiple myeloma.

Dr. Rajkumar on Significance of SWOG S0777 Study for Multiple Myeloma

April 04, 2016

S. Vincent Rajkumar, MD, professor of Medicine at Mayo Clinic, discusses the significance of the phase III SWOG S0777 study, which looked at bortezomib, lenalidomide, and dexamethasone versus lenalidomide and dexamethasone in patients with previously untreated multiple myeloma.